.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Bringing Oncology Biosimilars to Patients

EP. 1: Biosimilars, Private Payers, and Pharmacy-Level Substitution

January 24th 2018

EP. 2: Patient Assistance Programs and Biosimilars

January 24th 2018

EP. 3: Manufacturers and the Cost of Biosimilars and Biologics

January 24th 2018

EP. 4: Diversity in Clinical Trials for Biosimilars

January 24th 2018

EP. 5: The FDA and Diversity in Clinical Trials

January 24th 2018

EP. 6: Oncology Biosimilars Making a Difference for Patients

January 24th 2018

EP. 7: Putting Patients at the Center of the Biosimilar Conversation

January 24th 2018